最新の試験

EudraCT Number: 2004-000406-51

Sponsor Protocol Number: EMD20001

Start Date: 2004-09-16

Sponsor Name: GlaxoSmithKline

Full Title: A Prospective, Randomized, Double-blind, Placebo Controlled, Dose Ranging, Multi-Center Study of the Safety and Efficacy of Three Days Continuous Intravenous Infusion of GR270773 in the Treatment o...

Medical condition: Suspected or Confirmed Gram-negative Severe Sepsis in Adults

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FI (Completed) ES (Completed) CZ (Completed) LV (Completed) AT (Completed) HU (Completed) DK (Completed)

Trial results: View results

EudraCT Number: 2004-000632-82

Sponsor Protocol Number: AC-052-333

Start Date: 2004-09-16

Sponsor Name: Actelion Pharmaceuticals Ltd.

Full Title: Long term bosentan open label extension of the RAPIDS-2 study in Systemic Sclerosis patients with ischemic digital ulcers

Medical condition: SSc is a multi-system disorder of unknown etiology characterized by fibrosis and vascular obliteration in the skin and visceral organs. The pathogenesis of SSc involves immunologic mechanisms vascu...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2004-000530-37

Sponsor Protocol Number: 24978

Start Date: 2004-09-16

Sponsor Name: Serono International S.A.

Full Title: A multicentre, randomised, double blind, placebo controlled phase III study of subcutaneously administered onercept in the initial treatment and continued treatment after extended therapy in subjec...

Medical condition: Psoriasis is an inflammatory skin disorder that affects between 1 and 2% of the population. It is characterised by an increased proliferation of the epidermis, and presents as well-defined thickene...

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10037153		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: LT (Completed) LV (Completed) EE (Completed)

Trial results: View results

EudraCT Number: 2004-001662-41

Sponsor Protocol Number: BAP00154

Start Date: 2004-09-16

Sponsor Name: Basilea Pharmaceutica Ltd

Full Title: A Phase III, Randomized, Double-Blind Study of Ceftobiprole versus Vancomycin in the Treatment of Complicated Skin and Skin Structure Infections

Medical condition: Complicated skin and skin structure infections

Disease:	Version	SOC Term	Classification Code	Term	Level
	LLT		10024768		code

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: LT (Completed) LV (Completed) HU (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2004-001730-17

Sponsor Protocol Number: BAP00248/307

Start Date: 2004-09-16

Sponsor Name: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Full Title: A Phase 3, Randomized Double-Blind Study of Ceftobiprole Medocaril Versus Linezolid Plus Ceftazidime in the Treatment of Nosocomial Pneumonia

Medical condition: Nosocomial Pneumonia

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10052596	Nosocomial pneumonia	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: LT (Completed) LV (Completed) HU (Completed) GB (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2004-001069-17

Sponsor Protocol Number: CSPI135ZDE04

Start Date: 2004-09-16

Sponsor Name: Novartis Pharma GmbH

Full Title: A double-blind, active-controlled, randomized, multicenter, parallel-group 2 day comparison of 1000 mg propyphenazone / 80 mg codeine (applied as two suppositories) combination therapy versus a 100...

Medical condition: acute, at least moderate to severe biliary or urogenital pain

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10004670		low

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: LT (Completed)

Trial results: View results

EudraCT Number: 2004-001648-64

Sponsor Protocol Number: No EP-24332T-A014

Start Date: 2004-09-16

Sponsor Name: ardana LTD

Full Title: A Phase II multicentre, open-label study investigating the pharmacokinetics, pharmacodynamics, efficacy and safety of a loading dose regimen of a new GnRH antagonist, Teverelix 90 mg, long-acting f...

Medical condition: advanced prostate cancer

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male

Trial protocol: LT (Completed)

Trial results: (No results available)

EudraCT Number: 2006-001217-15

Sponsor Protocol Number: 85/04/04

Start Date: 2004-09-16

Sponsor Name: Lassila Riitta

Full Title: PRO-FEIBA. Asetelma on selkeä etenevä satunnaistettu kaksisuuntainen tutkimus aktivoitujen hyytymistekijöiden (aPCC, activated prothrombin complex concentrate) vaikutuksesta vaikeaa A hemofiliaa sa...

Medical condition: A-hemofilia

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male

Trial protocol: FI (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-001590-26

Sponsor Protocol Number: MAS QUE NADA

Start Date: 2004-09-15

Sponsor Name: OSPEDALE S. RAFFAELE

Full Title: NATIONAL, MULTICENTER, RANDOMIZED,OPEN STUDY TO EVALUATE EFFICACY AND SAFETY OF LAMIVUDINE (300 MG QD) MONOTHERAPY AS AN ALTERNATIVE TO THERAPEUTIC INTERRUPTION IN PAZIENTS AFFECTED BY HIV-1, IN VI...

Medical condition: HIV MONOTHERAPY TREATMENT , AS THERAPEUTIC MAINTENANCE, DURING INTERRUPTION OF ANTIVIRAL THERAPY

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10021428		SOC

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2004-000050-23

Sponsor Protocol Number: 28130

Start Date: 2004-09-15

Sponsor Name: NV Organon

Full Title: Prospective, double-blind, randomized, placebo-controlled dose finding study of the efficacy and safety of 2 target doses of Org 34517 used as adjunctive therapy in subjects with psychotic major de...

Medical condition: Psychotic major depression (major depressive episode, severe, with psychotic features)

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10037250		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed) GB (Completed)

Trial results: View results

最新の試験

スポンサーと協力者

医学的状態

薬物療法